Regenerative Medicine: Key Developments in Regulation and Commercialization
ARM is a proud partner of the Food and Drug Law Institute’s Regenerative Medicine: Key Developments in Regulation & Commercialization conference. This meeting will take place in both Washington D.C. and San Francisco, CA on June 27, 2012. Regenerative Medicine Forum Newsletter subscribers may register for this must-attend event, and receive a 15% discount, by using the promotional code: REGENMED2012.
More information
